These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23975040)

  • 1. The Rag2⁻Il2rb⁻Dmd⁻ mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies.
    Vallese D; Negroni E; Duguez S; Ferry A; Trollet C; Aamiri A; Vosshenrich CA; Füchtbauer EM; Di Santo JP; Vitiello L; Butler-Browne G; Mouly V
    Mol Ther; 2013 Oct; 21(10):1950-7. PubMed ID: 23975040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removing the immune response from muscular dystrophy research.
    Chamberlain JS
    Mol Ther; 2013 Oct; 21(10):1821-2. PubMed ID: 24081124
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.
    Kimura E; Han JJ; Li S; Fall B; Ra J; Haraguchi M; Tapscott SJ; Chamberlain JS
    Hum Mol Genet; 2008 Aug; 17(16):2507-17. PubMed ID: 18511457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice.
    Fakhfakh R; Michaud A; Tremblay JP
    Mol Ther; 2011 Jan; 19(1):204-10. PubMed ID: 20700111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation.
    Cui CH; Uyama T; Miyado K; Terai M; Kyo S; Kiyono T; Umezawa A
    Mol Biol Cell; 2007 May; 18(5):1586-94. PubMed ID: 17314403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenotransplantation of embryonic precursors of human myogenesis for the correction of dystrophinopathy in mice with hereditary muscular dystrophy.
    Yarygin VN; Sukhikh GT; Sitnikov VF; Stenina MA; Kuznetsov AB; Poltavtseva RA; Krivov LI; Voevodin DA; Savchuk VI; Revishchin AV; Korochkin LI; Aleksandrova MA
    Bull Exp Biol Med; 2003 Jul; 136(1):88-92. PubMed ID: 14534620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle.
    Gibson AJ; Karasinski J; Relvas J; Moss J; Sherratt TG; Strong PN; Watt DJ
    J Cell Sci; 1995 Jan; 108 ( Pt 1)():207-14. PubMed ID: 7738097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell transplantation and gene therapy in muscular dystrophy.
    Morgan JE; Partridge TA
    Bioessays; 1992 Sep; 14(9):641-5. PubMed ID: 1365921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.
    Song Y; Morales L; Malik AS; Mead AF; Greer CD; Mitchell MA; Petrov MT; Su LT; Choi ME; Rosenblum ST; Lu X; VanBelzen DJ; Krishnankutty RK; Balzer FJ; Loro E; French R; Propert KJ; Zhou S; Kozyak BW; Nghiem PP; Khurana TS; Kornegay JN; Stedman HH
    Nat Med; 2019 Oct; 25(10):1505-1511. PubMed ID: 31591596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
    Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS
    Nature; 1993 Aug; 364(6439):725-9. PubMed ID: 8355788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
    Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
    Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice.
    Di Certo MG; Corbi N; Strimpakos G; Onori A; Luvisetto S; Severini C; Guglielmotti A; Batassa EM; Pisani C; Floridi A; Benassi B; Fanciulli M; Magrelli A; Mattei E; Passananti C
    Hum Mol Genet; 2010 Mar; 19(5):752-60. PubMed ID: 19965907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coisogenic all-plus-one immunization: a model for identifying missing proteins in null-mutant conditions. Antibodies to dystrophin in mdx mouse after transplantation of muscle from normal coisogenic donor.
    Bittner RE; Streubel B; Shorny S; Schaden G; Voit T; Höger H
    Neuropediatrics; 1994 Aug; 25(4):176-82. PubMed ID: 7824089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative transcriptome analysis of muscular dystrophy models Large(myd), Dmd(mdx)/Large(myd) and Dmd(mdx): what makes them different?
    Almeida CF; Martins PC; Vainzof M
    Eur J Hum Genet; 2016 Aug; 24(9):1301-9. PubMed ID: 26932192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice.
    Phelps SF; Hauser MA; Cole NM; Rafael JA; Hinkle RT; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 1995 Aug; 4(8):1251-8. PubMed ID: 7581361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD45 fraction bone marrow cells as potential delivery vehicles for genetically corrected dystrophin loci.
    Kapsa RM; Wong SH; Bertoncello I; Quigley AF; Williams B; Sells K; Marotta R; Kita M; Simmons P; Byrne E; Kornberg AJ
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S61-6. PubMed ID: 12206798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice.
    Krämer R; Lochmüller H; Abicht A; Rüdel R; Brinkmeier H
    Neuromuscul Disord; 1998 Dec; 8(8):542-50. PubMed ID: 10093060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models.
    Quenneville SP; Chapdelaine P; Skuk D; Paradis M; Goulet M; Rousseau J; Xiao X; Garcia L; Tremblay JP
    Mol Ther; 2007 Feb; 15(2):431-8. PubMed ID: 17235323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy.
    Wells DJ; Wells KE; Asante EA; Turner G; Sunada Y; Campbell KP; Walsh FS; Dickson G
    Hum Mol Genet; 1995 Aug; 4(8):1245-50. PubMed ID: 7581360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
    Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.